Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- presencia de factores de riesgo
- preocupación excesiva durante al menos 6 meses
- la ansiedad no se limita a otro trastorno de salud mental
- ansiedad que no se debe a medicamentos o sustancias
- tensión muscular
- alteración del sueño
- fatiga
- inquietud
- irritabilidad
- mala concentración
Otros factores de diagnóstico
- cefalea
- sudoración
- mareos
- síntomas gastrointestinales
- dolores musculares
- aumento de la frecuencia cardíaca
- disnea
- temblor
- respuesta de susto exagerada
- dolor torácico
Factores de riesgo
- antecedentes familiares de ansiedad
- estrés emocional o físico
- Antecedentes de traumatismo físico, sexual o emocional
- otro trastorno de ansiedad
- afección crónica de la salud física
- sexo femenino
Pruebas diagnósticas
Pruebas diagnósticas que deben considerarse
- pruebas de función tiroidea
- cribado de tóxicos en orina
- orina de 24 horas para ácido vanililmandélico y metanefrinas
- pruebas funcionales respiratorias
- electrocardiograma (ECG)
Algoritmo de tratamiento
Colaboradores
Autores
Research Director
Consultant Psychiatrist
Southern District Health Board
Senior Lecturer
Department of Psychological Medicine
Dunedin School of Medicine
Otago University
Dunedin
New Zealand
Divulgaciones
CG is an author of the Royal Australian and New Zealand College of Psychiatrists clinical practice guideline on social phobia, panic disorder, and generalised anxiety disorder. He is a contributor to the Cochrane Common Mental Disorders group, writing on generalised anxiety disorder, and has authored papers relating to heterogeneity of the database separately to Cochrane work. Otago University has commercial and research relationships with multiple pharmaceutical companies. He is an author of a number of references cited in this topic.
Dr Christopher Gale would like to gratefully acknowledge Dr Richard P. Swinson, Dr Elizabeth Hoge, and Dr Phebe Tucker, previous contributors to this topic.
Divulgaciones
RPS has personally received royalties for articles published in UpToDate (Wolters Kluwer) and the Compendium of Therapeutic Choices, 2nd edition (Canadian Pharmacists Association). EH is an author of a number of references cited in this topic. PT has done research for GlaxoSmithKline, Bristol-Myers Squibb, Wyeth Pharmaceuticals, Astra-Zeneca, Cephalon, Inc., and Ortho-McNeil. She has also consulted for Forest Pharmaceuticals and received honoraria from Pfizer, Inc. and Forest Pharmaceuticals.
Revisores por pares
Research Director
University of Alabama
School of Medicine Tuscaloosa Campus
College of Community Health Sciences
Tuscaloosa
AL
Divulgaciones
LD declares that she has no competing interests.
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad